Actively Recruiting
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
Led by Thunder Bay Regional Health Research Institute · Updated on 2024-04-18
100
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
CONDITIONS
Official Title
TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age at the time of enrollment.
- Patients with visual signs of bladder tumor by outpatient cystoscopy are eligible.
You will not qualify if you...
- Tumors not suitable for laser resection, such as obvious muscle-invasive or metastatic tumors.
- Presence of synchronous urethral tumors or upper urinary tract tumors.
- History of carcinoma in situ.
- Contracted bladder.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada, P7B 6V4
Actively Recruiting
Research Team
R
Rabail Siddiqui
CONTACT
S
Shalyn Littlefield
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here